1. A simple characterization of dynamic changes in circulating CD8+PD1+ lymphocytes early predicts response to atezolizumab-bevacizumab in hepatocellular carcinoma. (March 2023) Authors: Giovannini, C.; Suzzi, F.; Tovoli, F.; Bruccoleri, M.; Marseglia, M.; Alimenti, E.; Fornari, F.; Iavarone, M.; Piscaglia, F.; Gramantieri, L. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 1 Page Start: S13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. In hepatocellular carcinoma miR-494 up-regulates the AKT/mTOR pathway and is involved in Sorafenib resistance. (10th February 2016) Authors: Pollutri, D.; Patrizi, C.; Marinelli, S.; Ferracin, M.; Negrini, M.; Toaldo, M. Baron; Bolondi, L.; Gramantieri, L.; Fornari, F. Journal: Digestive and liver disease Issue: Volume 48(2016)Supplement 1 Page Start: e28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. MiR-122 targets SerpinB3 and is involved in Sorafenib resistance in hepatocellular carcinoma. Issue 1 (16th February 2017) Authors: Pollutri, D.; Fornari, F.; Turato, C.; Villano, G.; Quarta, S.; Ruvoletto, M.; Bolondi, L.; Gramantieri, L.; Pontisso, P. Journal: Digestive and liver disease Issue: Volume 49:Issue 1(2017)Supplement Page Start: e28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. MiR-494 induces metabolic reprogramming through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma. (March 2023) Authors: Galvani, G.; Leoni, I.; Bergamini, C.; Rizzardi, N.; Melli, M.; Coada, C.A.; Monti, E.; Giovannini, C.; Liparulo, I.; Ferracin, M.; Ravaioli, M.; Cescon, M.; Vasuri, F.; Piscaglia, F.; Negrini, M.; Stefanelli, C.; Fato, R.; Gramantieri, L.; Fornari, F. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 1 Page Start: S47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Perfusion analysis with dynamic contrast enhanced ultrasound for the diagnosis of hepatocellular carcinoma: A pilot study of a novel parameter aiming to improve the detection of wash-out. (March 2021) Authors: Mulazzani, L.; Forgione, A.; Di Bonaventura, C.; Terzi, E.; Gramantieri, L.; Lyshchik, A.; Piscaglia, F. Journal: Digestive and liver disease Issue: Volume 53:(2021)Supplement 1 Page Start: S34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗